Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glomerulonephritis | 19 | 2022 | 75 | 4.480 |
Why?
|
Receptors, Complement | 28 | 2014 | 46 | 4.190 |
Why?
|
Complement Factor H | 17 | 2022 | 34 | 3.800 |
Why?
|
Complement System Proteins | 19 | 2023 | 81 | 3.670 |
Why?
|
Complement Activation | 25 | 2023 | 81 | 3.180 |
Why?
|
Kidney Glomerulus | 25 | 2016 | 123 | 2.900 |
Why?
|
Complement Inactivator Proteins | 16 | 2021 | 27 | 2.670 |
Why?
|
Complement C3 | 20 | 2020 | 58 | 2.490 |
Why?
|
Kidney | 23 | 2022 | 1241 | 2.160 |
Why?
|
Lupus Nephritis | 9 | 2013 | 78 | 2.090 |
Why?
|
Antigen-Antibody Complex | 10 | 2015 | 87 | 1.960 |
Why?
|
Receptor, Anaphylatoxin C5a | 10 | 2020 | 21 | 1.940 |
Why?
|
Receptors, Complement 3b | 22 | 2010 | 39 | 1.860 |
Why?
|
Lupus Erythematosus, Systemic | 14 | 2017 | 206 | 1.840 |
Why?
|
Kidney Diseases | 11 | 2021 | 418 | 1.690 |
Why?
|
Immune Complex Diseases | 6 | 2022 | 19 | 1.580 |
Why?
|
Mice | 77 | 2022 | 11352 | 1.500 |
Why?
|
Immunoglobulin G | 14 | 2015 | 456 | 1.470 |
Why?
|
Animals | 111 | 2022 | 26582 | 1.450 |
Why?
|
Complement C3a | 4 | 2018 | 11 | 1.410 |
Why?
|
Disease Models, Animal | 26 | 2018 | 2232 | 1.370 |
Why?
|
Complement C5a | 10 | 2020 | 24 | 1.360 |
Why?
|
Glomerulonephritis, Membranous | 5 | 2013 | 24 | 1.320 |
Why?
|
Mice, Inbred C57BL | 33 | 2022 | 3092 | 1.210 |
Why?
|
Serum Sickness | 6 | 2015 | 12 | 1.010 |
Why?
|
Reperfusion Injury | 5 | 2014 | 131 | 0.980 |
Why?
|
Lupus Vasculitis, Central Nervous System | 5 | 2016 | 11 | 0.890 |
Why?
|
Diabetic Nephropathies | 4 | 2011 | 248 | 0.890 |
Why?
|
Blood Platelets | 6 | 2010 | 149 | 0.890 |
Why?
|
CD55 Antigens | 3 | 2009 | 20 | 0.870 |
Why?
|
CD59 Antigens | 7 | 2009 | 17 | 0.860 |
Why?
|
Apoptosis | 17 | 2016 | 1683 | 0.840 |
Why?
|
Mice, Inbred MRL lpr | 16 | 2016 | 36 | 0.840 |
Why?
|
Acute Kidney Injury | 6 | 2004 | 295 | 0.830 |
Why?
|
Mice, Knockout | 21 | 2022 | 1924 | 0.830 |
Why?
|
Brain | 13 | 2016 | 2216 | 0.780 |
Why?
|
Monocytes | 3 | 2018 | 214 | 0.770 |
Why?
|
Glomerulonephritis, Membranoproliferative | 6 | 2012 | 14 | 0.770 |
Why?
|
Complement C5 | 3 | 2011 | 14 | 0.760 |
Why?
|
Up-Regulation | 9 | 2017 | 712 | 0.730 |
Why?
|
Glomerular Mesangium | 4 | 2008 | 23 | 0.730 |
Why?
|
Rats | 26 | 2012 | 3990 | 0.700 |
Why?
|
Neutrophils | 6 | 2009 | 307 | 0.700 |
Why?
|
Podocytes | 6 | 2012 | 30 | 0.660 |
Why?
|
CD11b Antigen | 2 | 2015 | 36 | 0.610 |
Why?
|
Kidney Failure, Chronic | 4 | 2021 | 509 | 0.600 |
Why?
|
Brain Diseases, Metabolic | 2 | 2007 | 9 | 0.580 |
Why?
|
Glomerulosclerosis, Focal Segmental | 2 | 2009 | 38 | 0.580 |
Why?
|
Oligonucleotide Array Sequence Analysis | 7 | 2008 | 689 | 0.570 |
Why?
|
Nephritis, Interstitial | 5 | 2011 | 47 | 0.560 |
Why?
|
Leukocytes | 3 | 2015 | 202 | 0.550 |
Why?
|
Apoferritins | 7 | 2022 | 15 | 0.550 |
Why?
|
Inflammation | 7 | 2018 | 920 | 0.540 |
Why?
|
Macrophages | 6 | 2022 | 554 | 0.540 |
Why?
|
Carboxypeptidases | 1 | 2015 | 35 | 0.530 |
Why?
|
Amino Acids | 2 | 2007 | 252 | 0.530 |
Why?
|
Receptors, Cell Surface | 11 | 2005 | 286 | 0.520 |
Why?
|
Hepatitis B | 1 | 2015 | 74 | 0.520 |
Why?
|
Receptors, IgG | 1 | 2015 | 52 | 0.510 |
Why?
|
Cells, Cultured | 16 | 2017 | 2818 | 0.500 |
Why?
|
Hepatitis C | 2 | 2015 | 208 | 0.490 |
Why?
|
NF-kappa B | 6 | 2015 | 444 | 0.490 |
Why?
|
Complement Pathway, Alternative | 4 | 2021 | 13 | 0.490 |
Why?
|
Blood-Brain Barrier | 6 | 2015 | 70 | 0.480 |
Why?
|
Neutrophil Infiltration | 3 | 2009 | 28 | 0.480 |
Why?
|
T-Lymphocytes | 4 | 2012 | 1195 | 0.480 |
Why?
|
Endothelium, Vascular | 5 | 2016 | 435 | 0.470 |
Why?
|
Thrombotic Microangiopathies | 1 | 2013 | 21 | 0.470 |
Why?
|
Kidney Tubules | 3 | 2010 | 94 | 0.460 |
Why?
|
Receptors, Complement 3d | 6 | 2009 | 14 | 0.460 |
Why?
|
Genetic Predisposition to Disease | 2 | 2014 | 2271 | 0.460 |
Why?
|
Kidney Transplantation | 7 | 2009 | 849 | 0.460 |
Why?
|
Glucose | 2 | 2007 | 638 | 0.460 |
Why?
|
RNA, Messenger | 16 | 2010 | 1981 | 0.460 |
Why?
|
Antibodies, Antinuclear | 3 | 2010 | 83 | 0.440 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2010 | 683 | 0.430 |
Why?
|
Recombinant Fusion Proteins | 5 | 2003 | 557 | 0.410 |
Why?
|
Recombinant Proteins | 5 | 2005 | 1014 | 0.410 |
Why?
|
Mice, Inbred BALB C | 7 | 2010 | 1047 | 0.410 |
Why?
|
Kidney Tubules, Proximal | 2 | 2009 | 61 | 0.410 |
Why?
|
Erythrocytes | 2 | 2010 | 255 | 0.400 |
Why?
|
Lipoproteins, LDL | 1 | 2011 | 83 | 0.390 |
Why?
|
Membrane Glycoproteins | 4 | 2004 | 428 | 0.380 |
Why?
|
Gene Expression Profiling | 7 | 2014 | 1384 | 0.380 |
Why?
|
MicroRNAs | 3 | 2014 | 534 | 0.380 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2011 | 1373 | 0.370 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2010 | 26 | 0.370 |
Why?
|
Ureteral Obstruction | 2 | 2013 | 67 | 0.370 |
Why?
|
Lipopolysaccharides | 5 | 2007 | 286 | 0.370 |
Why?
|
Signal Transduction | 11 | 2016 | 3241 | 0.360 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 2 | 2007 | 43 | 0.360 |
Why?
|
Receptors, Fc | 1 | 2009 | 33 | 0.350 |
Why?
|
Mesangial Cells | 1 | 2009 | 7 | 0.350 |
Why?
|
Pichia | 3 | 2003 | 29 | 0.350 |
Why?
|
Clusterin | 2 | 2008 | 13 | 0.340 |
Why?
|
Serum Albumin | 1 | 2009 | 130 | 0.340 |
Why?
|
Mice, Transgenic | 10 | 2010 | 1540 | 0.340 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2021 | 350 | 0.340 |
Why?
|
RNA Splicing | 1 | 2010 | 142 | 0.340 |
Why?
|
Gene Expression Regulation | 7 | 2014 | 1920 | 0.340 |
Why?
|
Complement Factor B | 2 | 2012 | 9 | 0.330 |
Why?
|
Antigens, Surface | 10 | 2005 | 101 | 0.330 |
Why?
|
Sepsis | 3 | 2007 | 306 | 0.330 |
Why?
|
Gastrointestinal Microbiome | 3 | 2021 | 455 | 0.330 |
Why?
|
Blood Urea Nitrogen | 4 | 2010 | 34 | 0.330 |
Why?
|
Kidney Function Tests | 4 | 2016 | 123 | 0.320 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2009 | 203 | 0.320 |
Why?
|
Protein Processing, Post-Translational | 1 | 2010 | 371 | 0.320 |
Why?
|
Fibronectins | 1 | 2008 | 93 | 0.320 |
Why?
|
bcl-X Protein | 1 | 2007 | 52 | 0.320 |
Why?
|
Atherosclerosis | 1 | 2011 | 244 | 0.310 |
Why?
|
Male | 33 | 2020 | 40966 | 0.310 |
Why?
|
Antigens, CD | 2 | 2002 | 458 | 0.300 |
Why?
|
Dysbiosis | 2 | 2018 | 70 | 0.300 |
Why?
|
Encephalitis | 1 | 2007 | 104 | 0.300 |
Why?
|
Behavior, Animal | 2 | 2007 | 373 | 0.290 |
Why?
|
Muscle, Skeletal | 3 | 2020 | 449 | 0.290 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2006 | 21 | 0.290 |
Why?
|
Inflammation Mediators | 3 | 2017 | 154 | 0.280 |
Why?
|
Humans | 40 | 2021 | 86644 | 0.280 |
Why?
|
Endotoxemia | 2 | 2004 | 18 | 0.280 |
Why?
|
Lupus Vulgaris | 1 | 2005 | 4 | 0.280 |
Why?
|
Transgenes | 3 | 2009 | 180 | 0.270 |
Why?
|
Albuminuria | 4 | 2009 | 153 | 0.260 |
Why?
|
Bone Marrow Cells | 1 | 2006 | 253 | 0.260 |
Why?
|
Mice, Mutant Strains | 4 | 2009 | 229 | 0.260 |
Why?
|
Vitamin D | 2 | 2007 | 261 | 0.250 |
Why?
|
Diacylglycerol Kinase | 2 | 2016 | 5 | 0.250 |
Why?
|
Autoimmune Diseases | 2 | 2004 | 241 | 0.250 |
Why?
|
Rats, Sprague-Dawley | 10 | 2007 | 1219 | 0.240 |
Why?
|
Bacteria | 2 | 2018 | 447 | 0.240 |
Why?
|
Fibrosis | 4 | 2022 | 203 | 0.240 |
Why?
|
Aquaporins | 1 | 2003 | 14 | 0.240 |
Why?
|
Renal Insufficiency | 3 | 2011 | 114 | 0.240 |
Why?
|
Curcumin | 2 | 2013 | 15 | 0.230 |
Why?
|
Energy Metabolism | 1 | 2005 | 271 | 0.230 |
Why?
|
Molecular Sequence Data | 8 | 2012 | 3030 | 0.220 |
Why?
|
Base Sequence | 8 | 2012 | 2330 | 0.220 |
Why?
|
Leukemia Virus, Murine | 1 | 2002 | 18 | 0.220 |
Why?
|
Solubility | 5 | 2003 | 177 | 0.220 |
Why?
|
Extracellular Matrix Proteins | 3 | 2007 | 123 | 0.220 |
Why?
|
Retroviridae | 1 | 2002 | 79 | 0.220 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 1 | 2002 | 16 | 0.210 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2002 | 88 | 0.210 |
Why?
|
Chemokines | 3 | 2007 | 73 | 0.210 |
Why?
|
Pinocytosis | 1 | 2021 | 6 | 0.200 |
Why?
|
Gene Expression | 7 | 2020 | 1284 | 0.200 |
Why?
|
Lymphocyte Depletion | 2 | 2013 | 97 | 0.200 |
Why?
|
Membrane Proteins | 2 | 2005 | 1196 | 0.200 |
Why?
|
Cresols | 1 | 2021 | 17 | 0.200 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2010 | 879 | 0.200 |
Why?
|
Renal Circulation | 1 | 2001 | 61 | 0.200 |
Why?
|
DNA Primers | 6 | 2008 | 543 | 0.200 |
Why?
|
Nitric Oxide Synthase Type II | 5 | 2010 | 86 | 0.200 |
Why?
|
Arthritis, Rheumatoid | 1 | 2002 | 166 | 0.190 |
Why?
|
Lipopolysaccharide Receptors | 1 | 2000 | 23 | 0.190 |
Why?
|
Physical Endurance | 1 | 2020 | 9 | 0.190 |
Why?
|
Antibodies | 4 | 2009 | 350 | 0.190 |
Why?
|
Receptors, Immunologic | 1 | 2001 | 135 | 0.190 |
Why?
|
Endothelial Cells | 4 | 2021 | 428 | 0.190 |
Why?
|
Chronic Disease | 4 | 2013 | 971 | 0.190 |
Why?
|
Cholesterol, LDL | 1 | 2021 | 222 | 0.180 |
Why?
|
Aorta | 1 | 2021 | 280 | 0.180 |
Why?
|
Chemotaxis, Leukocyte | 2 | 2011 | 38 | 0.180 |
Why?
|
Endothelium | 2 | 2016 | 59 | 0.180 |
Why?
|
Ischemia | 1 | 2001 | 243 | 0.170 |
Why?
|
Cerebrospinal Fluid | 1 | 1999 | 32 | 0.170 |
Why?
|
Antibodies, Monoclonal | 3 | 2009 | 1376 | 0.170 |
Why?
|
Complement Inactivating Agents | 1 | 2018 | 4 | 0.170 |
Why?
|
Amino Acid Sequence | 7 | 2012 | 2062 | 0.170 |
Why?
|
Intestinal Mucosa | 2 | 2017 | 797 | 0.170 |
Why?
|
Anti-Glomerular Basement Membrane Disease | 1 | 1998 | 4 | 0.160 |
Why?
|
Uremia | 1 | 2018 | 15 | 0.160 |
Why?
|
Cell Movement | 5 | 2022 | 758 | 0.160 |
Why?
|
Urea | 1 | 2018 | 57 | 0.160 |
Why?
|
Astrocytes | 3 | 2015 | 139 | 0.160 |
Why?
|
Complement C4 | 1 | 1998 | 10 | 0.160 |
Why?
|
Brain Edema | 3 | 2007 | 50 | 0.160 |
Why?
|
AIDS-Associated Nephropathy | 1 | 2017 | 2 | 0.160 |
Why?
|
Complement Membrane Attack Complex | 3 | 2007 | 20 | 0.160 |
Why?
|
Disease Progression | 4 | 2022 | 1531 | 0.160 |
Why?
|
Heroin Dependence | 1 | 2017 | 14 | 0.160 |
Why?
|
Myeloid Cells | 1 | 2018 | 98 | 0.160 |
Why?
|
Glycation End Products, Advanced | 1 | 2017 | 13 | 0.160 |
Why?
|
Lymphocyte Activation | 4 | 2009 | 728 | 0.160 |
Why?
|
B-Lymphocytes | 4 | 2009 | 724 | 0.150 |
Why?
|
Pancreas | 1 | 1999 | 239 | 0.150 |
Why?
|
Peritoneal Dialysis | 1 | 2017 | 32 | 0.150 |
Why?
|
Severity of Illness Index | 2 | 2015 | 1801 | 0.150 |
Why?
|
Macrophage-1 Antigen | 1 | 1997 | 17 | 0.150 |
Why?
|
Regeneration | 1 | 2018 | 143 | 0.150 |
Why?
|
Microglia | 1 | 2017 | 102 | 0.150 |
Why?
|
Autoimmunity | 3 | 2017 | 160 | 0.150 |
Why?
|
Bone and Bones | 1 | 2018 | 265 | 0.150 |
Why?
|
Frontal Lobe | 1 | 2017 | 130 | 0.150 |
Why?
|
Anti-Inflammatory Agents | 2 | 2013 | 339 | 0.150 |
Why?
|
Fas-Associated Death Domain Protein | 1 | 2016 | 7 | 0.150 |
Why?
|
HIV-1 | 1 | 2017 | 163 | 0.140 |
Why?
|
Coronary Artery Disease | 1 | 2021 | 350 | 0.140 |
Why?
|
Fracture Healing | 2 | 2007 | 34 | 0.140 |
Why?
|
Sequence Homology, Amino Acid | 4 | 2012 | 416 | 0.140 |
Why?
|
Epithelial Cells | 3 | 2007 | 669 | 0.140 |
Why?
|
Aquaporin 4 | 2 | 2007 | 8 | 0.140 |
Why?
|
Dinoprostone | 1 | 2016 | 69 | 0.140 |
Why?
|
Intestine, Small | 1 | 2018 | 303 | 0.140 |
Why?
|
Liver | 1 | 2021 | 1230 | 0.140 |
Why?
|
Receptors, Calcitriol | 2 | 2007 | 129 | 0.140 |
Why?
|
Cyclooxygenase 2 | 1 | 2016 | 100 | 0.140 |
Why?
|
Glycolysis | 2 | 2007 | 129 | 0.140 |
Why?
|
Extracellular Matrix | 3 | 2007 | 232 | 0.130 |
Why?
|
Diet | 2 | 2017 | 443 | 0.130 |
Why?
|
PTEN Phosphohydrolase | 2 | 2007 | 128 | 0.130 |
Why?
|
Renal Dialysis | 1 | 2018 | 355 | 0.130 |
Why?
|
C-Reactive Protein | 2 | 2007 | 190 | 0.130 |
Why?
|
Comorbidity | 2 | 2017 | 943 | 0.130 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2016 | 199 | 0.130 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2007 | 87 | 0.130 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2007 | 318 | 0.130 |
Why?
|
CD18 Antigens | 1 | 2015 | 22 | 0.130 |
Why?
|
Complement C3d | 2 | 2007 | 6 | 0.130 |
Why?
|
Immunity, Humoral | 1 | 2015 | 67 | 0.130 |
Why?
|
Hemolytic-Uremic Syndrome | 2 | 2006 | 9 | 0.130 |
Why?
|
Sheep | 2 | 2009 | 239 | 0.130 |
Why?
|
Fluorescent Antibody Technique, Indirect | 2 | 2005 | 68 | 0.120 |
Why?
|
Glomerular Filtration Rate | 1 | 2015 | 384 | 0.120 |
Why?
|
Transforming Growth Factor beta | 3 | 2007 | 301 | 0.120 |
Why?
|
Female | 12 | 2017 | 44533 | 0.120 |
Why?
|
Phosphorylation | 2 | 2007 | 1106 | 0.120 |
Why?
|
Proteinuria | 3 | 2012 | 107 | 0.120 |
Why?
|
Bone Marrow | 1 | 2015 | 435 | 0.110 |
Why?
|
Caspase 3 | 2 | 2016 | 159 | 0.110 |
Why?
|
DNA, Complementary | 2 | 2003 | 393 | 0.110 |
Why?
|
Cytokines | 4 | 2017 | 776 | 0.110 |
Why?
|
Nephritis | 1 | 2012 | 20 | 0.110 |
Why?
|
Microbiota | 1 | 2017 | 381 | 0.110 |
Why?
|
Precipitin Tests | 3 | 1997 | 108 | 0.100 |
Why?
|
Cloning, Molecular | 2 | 2003 | 646 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2007 | 322 | 0.100 |
Why?
|
Antiviral Agents | 1 | 2015 | 510 | 0.100 |
Why?
|
Protein Isoforms | 2 | 2010 | 270 | 0.100 |
Why?
|
Gliosis | 2 | 2009 | 35 | 0.100 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 243 | 0.100 |
Why?
|
Blotting, Northern | 3 | 1995 | 256 | 0.100 |
Why?
|
T-Lymphocyte Subsets | 2 | 2010 | 272 | 0.100 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2013 | 425 | 0.100 |
Why?
|
B-Lymphocyte Subsets | 1 | 2010 | 40 | 0.100 |
Why?
|
Blotting, Western | 4 | 2010 | 782 | 0.100 |
Why?
|
Species Specificity | 3 | 2004 | 678 | 0.090 |
Why?
|
Leukocyte Common Antigens | 2 | 2007 | 46 | 0.090 |
Why?
|
Cardiovascular Diseases | 1 | 2017 | 827 | 0.090 |
Why?
|
Wound Healing | 2 | 2016 | 344 | 0.090 |
Why?
|
Fluorescent Antibody Technique | 3 | 2018 | 316 | 0.090 |
Why?
|
CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2009 | 13 | 0.090 |
Why?
|
Cholesterol | 2 | 2021 | 356 | 0.090 |
Why?
|
Immunohistochemistry | 3 | 2018 | 1753 | 0.090 |
Why?
|
Microvilli | 1 | 2009 | 43 | 0.090 |
Why?
|
Organic Chemicals | 1 | 2009 | 33 | 0.090 |
Why?
|
Annexin A4 | 1 | 2009 | 2 | 0.090 |
Why?
|
Neurodegenerative Diseases | 1 | 2009 | 44 | 0.090 |
Why?
|
RNA, Small Interfering | 2 | 2008 | 547 | 0.090 |
Why?
|
HIV Infections | 1 | 2017 | 772 | 0.090 |
Why?
|
Heymann Nephritis Antigenic Complex | 2 | 2001 | 3 | 0.090 |
Why?
|
Immunoglobulin M | 1 | 2009 | 154 | 0.080 |
Why?
|
Cell Adhesion | 1 | 2010 | 420 | 0.080 |
Why?
|
Protein Phosphatase 2C | 1 | 2008 | 3 | 0.080 |
Why?
|
Calcitriol | 2 | 2007 | 174 | 0.080 |
Why?
|
Cell Adhesion Molecules | 2 | 2010 | 163 | 0.080 |
Why?
|
p21-Activated Kinases | 1 | 2008 | 15 | 0.080 |
Why?
|
Femoral Fractures | 2 | 2007 | 32 | 0.080 |
Why?
|
Antibody Formation | 1 | 2009 | 171 | 0.080 |
Why?
|
Thymus Gland | 1 | 2009 | 195 | 0.080 |
Why?
|
Mice, SCID | 1 | 2009 | 252 | 0.080 |
Why?
|
Cell Proliferation | 4 | 2009 | 1578 | 0.080 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2008 | 57 | 0.080 |
Why?
|
Albumins | 1 | 2009 | 133 | 0.080 |
Why?
|
Immunity, Cellular | 1 | 2009 | 177 | 0.080 |
Why?
|
Retinoblastoma-Like Protein p130 | 1 | 2008 | 7 | 0.080 |
Why?
|
Mice, Inbred NOD | 1 | 2008 | 187 | 0.080 |
Why?
|
Cytochromes c | 1 | 2007 | 27 | 0.080 |
Why?
|
Connective Tissue Growth Factor | 2 | 2007 | 14 | 0.080 |
Why?
|
bcl-2-Associated X Protein | 1 | 2007 | 47 | 0.080 |
Why?
|
I-kappa B Kinase | 1 | 2007 | 37 | 0.080 |
Why?
|
Fluorescent Dyes | 1 | 2009 | 242 | 0.080 |
Why?
|
Serum Albumin, Bovine | 1 | 2007 | 45 | 0.080 |
Why?
|
Transcription Factor RelA | 1 | 2007 | 49 | 0.080 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2007 | 41 | 0.080 |
Why?
|
Transcription Factor AP-1 | 1 | 2007 | 65 | 0.080 |
Why?
|
Risk Assessment | 1 | 2015 | 2261 | 0.080 |
Why?
|
Autoantibodies | 3 | 2009 | 267 | 0.080 |
Why?
|
Smad3 Protein | 1 | 2007 | 15 | 0.080 |
Why?
|
Proteins | 2 | 2003 | 777 | 0.080 |
Why?
|
Citric Acid Cycle | 1 | 2007 | 21 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-cbl | 1 | 2007 | 36 | 0.080 |
Why?
|
Cell Survival | 1 | 2010 | 969 | 0.080 |
Why?
|
CD40 Antigens | 1 | 2007 | 43 | 0.080 |
Why?
|
Prognosis | 1 | 2015 | 3679 | 0.080 |
Why?
|
Toll-Like Receptor 4 | 2 | 2007 | 88 | 0.080 |
Why?
|
Thrombin | 1 | 2007 | 61 | 0.080 |
Why?
|
Superoxide Dismutase | 1 | 2008 | 177 | 0.080 |
Why?
|
Horses | 1 | 2007 | 35 | 0.080 |
Why?
|
Mice, Nude | 1 | 2009 | 790 | 0.070 |
Why?
|
Chemokines, CXC | 1 | 2007 | 21 | 0.070 |
Why?
|
Brain Chemistry | 1 | 2007 | 121 | 0.070 |
Why?
|
Chemokine CCL2 | 1 | 2007 | 47 | 0.070 |
Why?
|
Diagnosis, Differential | 2 | 2012 | 1565 | 0.070 |
Why?
|
Repetitive Sequences, Amino Acid | 1 | 2006 | 12 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2007 | 179 | 0.070 |
Why?
|
Vitamin D-Binding Protein | 1 | 2006 | 7 | 0.070 |
Why?
|
Calbindin 1 | 1 | 2006 | 11 | 0.070 |
Why?
|
25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2006 | 10 | 0.070 |
Why?
|
Adipocytes | 1 | 2008 | 155 | 0.070 |
Why?
|
Calbindins | 1 | 2006 | 19 | 0.070 |
Why?
|
Chromatography, Affinity | 2 | 1997 | 81 | 0.070 |
Why?
|
S100 Calcium Binding Protein G | 1 | 2006 | 22 | 0.070 |
Why?
|
Molecular Weight | 2 | 1997 | 332 | 0.070 |
Why?
|
Immediate-Early Proteins | 2 | 2007 | 164 | 0.070 |
Why?
|
Brain Diseases | 1 | 2007 | 180 | 0.070 |
Why?
|
Actins | 2 | 2020 | 451 | 0.070 |
Why?
|
Complement C9 | 1 | 2005 | 3 | 0.070 |
Why?
|
Feces | 2 | 2018 | 319 | 0.070 |
Why?
|
Down-Regulation | 1 | 2007 | 504 | 0.070 |
Why?
|
Carbon Radioisotopes | 1 | 2005 | 35 | 0.070 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2007 | 302 | 0.070 |
Why?
|
Choline | 1 | 2005 | 23 | 0.070 |
Why?
|
Treatment Outcome | 2 | 2015 | 7993 | 0.070 |
Why?
|
Macular Degeneration | 1 | 2006 | 59 | 0.070 |
Why?
|
Peptide Fragments | 1 | 2007 | 460 | 0.070 |
Why?
|
Fractures, Bone | 1 | 2007 | 131 | 0.070 |
Why?
|
Benzhydryl Compounds | 1 | 2005 | 48 | 0.070 |
Why?
|
Nephrotic Syndrome | 1 | 2005 | 33 | 0.070 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2005 | 51 | 0.070 |
Why?
|
Alanine | 1 | 2005 | 85 | 0.060 |
Why?
|
Lactic Acid | 1 | 2005 | 90 | 0.060 |
Why?
|
Arginine | 1 | 2005 | 136 | 0.060 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2006 | 214 | 0.060 |
Why?
|
Glutamine | 1 | 2005 | 76 | 0.060 |
Why?
|
Protons | 1 | 2005 | 98 | 0.060 |
Why?
|
Databases, Nucleic Acid | 1 | 2005 | 41 | 0.060 |
Why?
|
Glutamic Acid | 1 | 2005 | 152 | 0.060 |
Why?
|
Databases, Protein | 1 | 2005 | 52 | 0.060 |
Why?
|
Cell Differentiation | 2 | 2008 | 1458 | 0.060 |
Why?
|
Cryoglobulins | 1 | 2004 | 4 | 0.060 |
Why?
|
Caspases | 1 | 2004 | 155 | 0.060 |
Why?
|
In Situ Nick-End Labeling | 3 | 2010 | 121 | 0.060 |
Why?
|
Gene Regulatory Networks | 1 | 2007 | 296 | 0.060 |
Why?
|
Oligonucleotide Probes | 1 | 2003 | 39 | 0.060 |
Why?
|
Injections, Intraperitoneal | 1 | 2004 | 102 | 0.060 |
Why?
|
Antigens | 1 | 2005 | 228 | 0.060 |
Why?
|
Procollagen | 1 | 2003 | 8 | 0.060 |
Why?
|
History, 20th Century | 1 | 2005 | 312 | 0.060 |
Why?
|
Immunoglobulin A | 1 | 2004 | 80 | 0.060 |
Why?
|
Ginsenosides | 1 | 2004 | 123 | 0.060 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2003 | 36 | 0.060 |
Why?
|
Phenotype | 3 | 2018 | 2378 | 0.060 |
Why?
|
Adrenal Cortex Hormones | 1 | 2005 | 263 | 0.060 |
Why?
|
Hippocampus | 1 | 2007 | 442 | 0.060 |
Why?
|
Complement Pathway, Classical | 1 | 2003 | 2 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 1 | 2005 | 279 | 0.060 |
Why?
|
Mice, Inbred C3H | 1 | 2004 | 370 | 0.060 |
Why?
|
Toll-Like Receptors | 1 | 2004 | 92 | 0.060 |
Why?
|
Puromycin Aminonucleoside | 1 | 2002 | 2 | 0.060 |
Why?
|
Nephrosis | 1 | 2002 | 3 | 0.060 |
Why?
|
Mice, Inbred NZB | 1 | 2002 | 13 | 0.060 |
Why?
|
Proteomics | 1 | 2005 | 212 | 0.060 |
Why?
|
Rats, Inbred Lew | 2 | 2004 | 186 | 0.060 |
Why?
|
Receptors, Angiotensin | 1 | 2002 | 15 | 0.060 |
Why?
|
Microscopy, Immunoelectron | 1 | 2002 | 29 | 0.060 |
Why?
|
Vasculitis | 1 | 2003 | 39 | 0.060 |
Why?
|
Cerebral Cortex | 1 | 2007 | 584 | 0.060 |
Why?
|
Dermatitis | 1 | 2003 | 32 | 0.060 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2002 | 20 | 0.050 |
Why?
|
Liver Failure | 1 | 2003 | 78 | 0.050 |
Why?
|
Tissue Distribution | 1 | 2002 | 290 | 0.050 |
Why?
|
Mice, Inbred Strains | 1 | 2002 | 307 | 0.050 |
Why?
|
Anemia, Hemolytic | 1 | 2002 | 19 | 0.050 |
Why?
|
Clodronic Acid | 1 | 2022 | 9 | 0.050 |
Why?
|
Nerve Degeneration | 1 | 2002 | 83 | 0.050 |
Why?
|
Models, Biological | 1 | 2009 | 1749 | 0.050 |
Why?
|
Blood Proteins | 1 | 2002 | 144 | 0.050 |
Why?
|
Cell Polarity | 1 | 2002 | 115 | 0.050 |
Why?
|
Organ Specificity | 2 | 2005 | 258 | 0.050 |
Why?
|
Complement C5b | 1 | 2001 | 2 | 0.050 |
Why?
|
Complement C3b | 1 | 2001 | 5 | 0.050 |
Why?
|
Nitric Oxide Synthase | 1 | 2002 | 125 | 0.050 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2002 | 143 | 0.050 |
Why?
|
Renin-Angiotensin System | 1 | 2002 | 133 | 0.050 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2022 | 78 | 0.050 |
Why?
|
Immunization, Passive | 1 | 2001 | 71 | 0.050 |
Why?
|
Chromosome Mapping | 1 | 2005 | 1074 | 0.050 |
Why?
|
RNA, Viral | 1 | 2002 | 327 | 0.050 |
Why?
|
Mutation | 1 | 2012 | 3968 | 0.050 |
Why?
|
Calcium | 1 | 2006 | 1156 | 0.050 |
Why?
|
Computational Biology | 1 | 2005 | 528 | 0.050 |
Why?
|
Staining and Labeling | 1 | 2001 | 165 | 0.050 |
Why?
|
Muscle Fatigue | 1 | 2020 | 6 | 0.050 |
Why?
|
Rotarod Performance Test | 1 | 2020 | 9 | 0.050 |
Why?
|
Quantitative Trait Loci | 1 | 2005 | 576 | 0.050 |
Why?
|
Fecal Microbiota Transplantation | 1 | 2021 | 62 | 0.050 |
Why?
|
Vimentin | 1 | 2020 | 44 | 0.050 |
Why?
|
Muscle Strength | 1 | 2020 | 31 | 0.050 |
Why?
|
Triglycerides | 1 | 2021 | 232 | 0.050 |
Why?
|
Age Factors | 1 | 2005 | 1851 | 0.050 |
Why?
|
Immunity, Innate | 1 | 2004 | 409 | 0.050 |
Why?
|
Blood Glucose | 1 | 2004 | 873 | 0.050 |
Why?
|
Diet, High-Fat | 1 | 2021 | 114 | 0.050 |
Why?
|
Cell Membrane | 1 | 2003 | 666 | 0.050 |
Why?
|
Fermentation | 1 | 2000 | 13 | 0.050 |
Why?
|
Hemolysis | 1 | 2000 | 61 | 0.050 |
Why?
|
DNA, Mitochondrial | 1 | 2020 | 183 | 0.040 |
Why?
|
Immunosuppressive Agents | 1 | 2005 | 977 | 0.040 |
Why?
|
Coronary Vessels | 1 | 2021 | 177 | 0.040 |
Why?
|
Immunoblotting | 1 | 2000 | 268 | 0.040 |
Why?
|
Genomics | 1 | 2005 | 720 | 0.040 |
Why?
|
Chemokine CXCL2 | 2 | 2010 | 16 | 0.040 |
Why?
|
Urease | 1 | 2018 | 3 | 0.040 |
Why?
|
Bone Resorption | 1 | 2018 | 41 | 0.040 |
Why?
|
Osteoclasts | 1 | 2018 | 33 | 0.040 |
Why?
|
Ribotyping | 1 | 2018 | 11 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 2002 | 470 | 0.040 |
Why?
|
Survival Analysis | 1 | 2002 | 1538 | 0.040 |
Why?
|
Osteoblasts | 1 | 2018 | 95 | 0.040 |
Why?
|
X-Ray Microtomography | 1 | 2018 | 80 | 0.040 |
Why?
|
Hydrolysis | 1 | 2018 | 141 | 0.040 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 1 | 2017 | 3 | 0.040 |
Why?
|
Homeodomain Proteins | 1 | 2002 | 536 | 0.040 |
Why?
|
Immunomodulation | 1 | 2017 | 55 | 0.040 |
Why?
|
Mating Factor | 1 | 1997 | 4 | 0.040 |
Why?
|
Immunization | 1 | 1998 | 158 | 0.040 |
Why?
|
Transformation, Genetic | 1 | 1997 | 40 | 0.040 |
Why?
|
DNA, Recombinant | 1 | 1997 | 67 | 0.040 |
Why?
|
Cadaver | 1 | 2017 | 185 | 0.040 |
Why?
|
Microscopy, Electron | 1 | 1998 | 503 | 0.040 |
Why?
|
Protein Sorting Signals | 1 | 1997 | 43 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2002 | 1169 | 0.040 |
Why?
|
Genetic Therapy | 1 | 1999 | 342 | 0.040 |
Why?
|
Membrane Transport Proteins | 1 | 2018 | 166 | 0.040 |
Why?
|
Administration, Oral | 1 | 2018 | 684 | 0.040 |
Why?
|
Peptides, Cyclic | 1 | 2016 | 43 | 0.040 |
Why?
|
Host-Pathogen Interactions | 1 | 2018 | 231 | 0.030 |
Why?
|
Junctional Adhesion Molecules | 1 | 2015 | 3 | 0.030 |
Why?
|
Claudin-5 | 1 | 2015 | 5 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2002 | 1208 | 0.030 |
Why?
|
Genetic Vectors | 1 | 1997 | 439 | 0.030 |
Why?
|
Homeostasis | 1 | 2017 | 409 | 0.030 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2015 | 66 | 0.030 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2015 | 75 | 0.030 |
Why?
|
Zonula Occludens-1 Protein | 1 | 2015 | 70 | 0.030 |
Why?
|
Neovascularization, Physiologic | 1 | 2016 | 133 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2017 | 337 | 0.030 |
Why?
|
Electric Impedance | 1 | 2015 | 104 | 0.030 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 115 | 0.030 |
Why?
|
Restriction Mapping | 1 | 1995 | 157 | 0.030 |
Why?
|
Neurons | 3 | 2010 | 1546 | 0.030 |
Why?
|
Pilot Projects | 1 | 2017 | 839 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 1997 | 927 | 0.030 |
Why?
|
DNA | 2 | 2012 | 1294 | 0.030 |
Why?
|
Permeability | 1 | 2014 | 137 | 0.030 |
Why?
|
Glycosylation | 1 | 1995 | 129 | 0.030 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1995 | 135 | 0.030 |
Why?
|
Spleen | 1 | 1995 | 430 | 0.030 |
Why?
|
Tight Junctions | 1 | 2015 | 149 | 0.030 |
Why?
|
Epithelium | 1 | 1995 | 319 | 0.030 |
Why?
|
Saccharomyces cerevisiae | 1 | 1997 | 434 | 0.030 |
Why?
|
Protein Transport | 1 | 2015 | 411 | 0.030 |
Why?
|
Middle Aged | 2 | 2017 | 25028 | 0.030 |
Why?
|
Peptides | 1 | 1997 | 639 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2005 | 2360 | 0.030 |
Why?
|
Atrophy | 1 | 2013 | 117 | 0.030 |
Why?
|
Actin Cytoskeleton | 1 | 2015 | 192 | 0.030 |
Why?
|
Alternative Splicing | 1 | 1995 | 201 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2013 | 211 | 0.030 |
Why?
|
Turkey | 1 | 2012 | 20 | 0.030 |
Why?
|
Diglycerides | 1 | 2012 | 22 | 0.030 |
Why?
|
Consanguinity | 1 | 2012 | 73 | 0.030 |
Why?
|
Biomarkers | 1 | 2018 | 1718 | 0.030 |
Why?
|
Child | 2 | 2015 | 6927 | 0.030 |
Why?
|
Primary Cell Culture | 1 | 2011 | 72 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 2011 | 154 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2003 | 3362 | 0.030 |
Why?
|
Aging | 1 | 2016 | 691 | 0.020 |
Why?
|
Dendritic Cells, Follicular | 1 | 2010 | 20 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2012 | 615 | 0.020 |
Why?
|
Pedigree | 1 | 2012 | 966 | 0.020 |
Why?
|
Clone Cells | 1 | 2010 | 213 | 0.020 |
Why?
|
Germinal Center | 1 | 2010 | 55 | 0.020 |
Why?
|
Adolescent | 2 | 2015 | 8981 | 0.020 |
Why?
|
Plasma Cells | 1 | 2010 | 80 | 0.020 |
Why?
|
Annexin A5 | 1 | 2010 | 20 | 0.020 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2010 | 71 | 0.020 |
Why?
|
ZAP-70 Protein-Tyrosine Kinase | 1 | 2009 | 18 | 0.020 |
Why?
|
Cell Line | 1 | 2014 | 2468 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2010 | 207 | 0.020 |
Why?
|
Adaptive Immunity | 1 | 2010 | 164 | 0.020 |
Why?
|
Receptors, AMPA | 1 | 2009 | 66 | 0.020 |
Why?
|
Azo Compounds | 1 | 2008 | 13 | 0.020 |
Why?
|
3T3-L1 Cells | 1 | 2008 | 32 | 0.020 |
Why?
|
I-kappa B Proteins | 1 | 2008 | 53 | 0.020 |
Why?
|
TNF Receptor-Associated Factor 2 | 1 | 2007 | 6 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2008 | 92 | 0.020 |
Why?
|
Luciferases | 1 | 2008 | 118 | 0.020 |
Why?
|
Streptozocin | 1 | 2007 | 54 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2009 | 444 | 0.020 |
Why?
|
CD40 Ligand | 1 | 2007 | 69 | 0.020 |
Why?
|
Chemokine CXCL1 | 1 | 2007 | 9 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2008 | 297 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2010 | 480 | 0.020 |
Why?
|
Protein Array Analysis | 1 | 2007 | 50 | 0.020 |
Why?
|
Ubiquitin | 1 | 2007 | 93 | 0.020 |
Why?
|
Chondrocytes | 1 | 2007 | 60 | 0.020 |
Why?
|
Ossification, Heterotopic | 1 | 2007 | 31 | 0.020 |
Why?
|
RNA Interference | 1 | 2008 | 369 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2007 | 222 | 0.020 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2007 | 190 | 0.020 |
Why?
|
Cell Death | 1 | 2007 | 256 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2009 | 425 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2007 | 278 | 0.020 |
Why?
|
Cohort Studies | 1 | 2012 | 2767 | 0.020 |
Why?
|
Genetic Variation | 1 | 2012 | 1351 | 0.020 |
Why?
|
Nephrectomy | 1 | 2008 | 294 | 0.020 |
Why?
|
Time Factors | 2 | 2004 | 5210 | 0.020 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2004 | 25 | 0.020 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2004 | 53 | 0.020 |
Why?
|
Survival | 1 | 2004 | 21 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2012 | 2357 | 0.020 |
Why?
|
Infant | 1 | 2010 | 3047 | 0.020 |
Why?
|
Transforming Growth Factor beta3 | 1 | 2004 | 16 | 0.020 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2004 | 15 | 0.020 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2004 | 40 | 0.010 |
Why?
|
Child, Preschool | 1 | 2010 | 3612 | 0.010 |
Why?
|
Protein Binding | 1 | 2007 | 1456 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2005 | 178 | 0.010 |
Why?
|
Neutron Diffraction | 1 | 2003 | 4 | 0.010 |
Why?
|
Ultracentrifugation | 1 | 2003 | 42 | 0.010 |
Why?
|
Consensus Sequence | 1 | 2003 | 64 | 0.010 |
Why?
|
Immunoglobulins | 1 | 2004 | 148 | 0.010 |
Why?
|
Solutions | 1 | 2003 | 85 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2004 | 692 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2009 | 2426 | 0.010 |
Why?
|
Liver Regeneration | 1 | 2003 | 32 | 0.010 |
Why?
|
X-Ray Diffraction | 1 | 2003 | 124 | 0.010 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2002 | 32 | 0.010 |
Why?
|
Sclerosis | 1 | 2002 | 28 | 0.010 |
Why?
|
Angiotensin II | 1 | 2002 | 94 | 0.010 |
Why?
|
Cell Division | 1 | 2004 | 696 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2004 | 912 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2003 | 408 | 0.010 |
Why?
|
Acute Disease | 1 | 2004 | 826 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2003 | 736 | 0.010 |
Why?
|
Liver Cirrhosis | 1 | 2003 | 297 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2004 | 1961 | 0.010 |
Why?
|
Insulin | 1 | 2004 | 1160 | 0.010 |
Why?
|
Young Adult | 1 | 2010 | 5976 | 0.010 |
Why?
|
Models, Molecular | 1 | 2003 | 1286 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2003 | 2705 | 0.010 |
Why?
|
Transcription Factors | 1 | 2003 | 1565 | 0.010 |
Why?
|
Adult | 1 | 2010 | 25648 | 0.010 |
Why?
|